Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Drug target identification, validation, characterisation and exploitation for treatment of Acanthamoeba (species) infections.

Roberts CW, Henriquez FL.

Exp Parasitol. 2010 Sep;126(1):91-6. doi: 10.1016/j.exppara.2009.11.016. Epub 2009 Dec 24. Review.

PMID:
20035751
2.

Three cases of Acanthamoeba keratitis diagnosed and treated in the early stage.

Ueki N, Eguchi H, Oogi Y, Shiota H, Yamane S, Umazume H, Mizui K.

J Med Invest. 2009 Aug;56(3-4):166-9.

3.

Acanthamoeba keratitis: diagnosis and treatment update 2009.

Dart JK, Saw VP, Kilvington S.

Am J Ophthalmol. 2009 Oct;148(4):487-499.e2. doi: 10.1016/j.ajo.2009.06.009. Epub 2009 Aug 5. Review.

PMID:
19660733
4.

The relative value of confocal microscopy and superficial corneal scrapings in the diagnosis of Acanthamoeba keratitis.

Tu EY, Joslin CE, Sugar J, Booton GC, Shoff ME, Fuerst PA.

Cornea. 2008 Aug;27(7):764-72. doi: 10.1097/ICO.0b013e31816f27bf.

PMID:
18650660
5.

Prognostic factors affecting visual outcome in Acanthamoeba keratitis.

Tu EY, Joslin CE, Sugar J, Shoff ME, Booton GC.

Ophthalmology. 2008 Nov;115(11):1998-2003. doi: 10.1016/j.ophtha.2008.04.038. Epub 2008 Jun 24.

6.

Fusarium and Acanthamoeba keratitis: can a single centre detect outbreaks?

Sansanayudh W, Cevallos V, Porco TC, Margolis TP, Lietman TM, Acharya NR.

Br J Ophthalmol. 2008 May;92(5):720-1. doi: 10.1136/bjo.2007.134171. No abstract available.

7.

Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.

Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR, Ficker L.

Am J Ophthalmol. 2008 Jan;145(1):130-5. Epub 2007 Nov 8.

PMID:
17996208
8.

Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis.

Parmar DN, Awwad ST, Petroll WM, Bowman RW, McCulley JP, Cavanagh HD.

Ophthalmology. 2006 Apr;113(4):538-47.

PMID:
16581415
9.

Delay in diagnosis and outcome of Acanthamoeba keratitis.

Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P.

Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):648-53.

PMID:
15221303
10.

Acanthamoeba: a difficult pathogen to evaluate and treat.

Mathers WD.

Cornea. 2004 May;23(4):325. No abstract available.

PMID:
15097123
11.

Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.

PĂ©rez-Santonja JJ, Kilvington S, Hughes R, Tufail A, Matheson M, Dart JK.

Ophthalmology. 2003 Aug;110(8):1593-600.

PMID:
12917179
12.

Acanthamoeba spp. as agents of disease in humans.

Marciano-Cabral F, Cabral G.

Clin Microbiol Rev. 2003 Apr;16(2):273-307. Review.

13.

Effect of steroids on Acanthamoeba cysts and trophozoites.

McClellan K, Howard K, Niederkorn JY, Alizadeh H.

Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2885-93.

PMID:
11687533
14.

Acanthamoeba keratitis: risk factors and outcome.

Illingworth CD, Cook SD, Karabatsas CH, Easty DL.

Br J Ophthalmol. 1995 Dec;79(12):1078-82.

15.

Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy.

Winchester K, Mathers WD, Sutphin JE, Daley TE.

Cornea. 1995 Jan;14(1):10-7.

PMID:
7712728
16.

Effects of corticosteroids in experimental Acanthamoeba keratitis.

John T, Lin J, Sahm D, Rockey JH.

Rev Infect Dis. 1991 Mar-Apr;13 Suppl 5:S440-2. No abstract available.

PMID:
1710818
Items per page

Supplemental Content

Write to the Help Desk